2-(Hydroxymethyl)pyridine CAS:586-98-1

2-(Hydroxymethyl)pyridine

Chemical Name:2-(Hydroxymethyl)pyridine
CAS.NO:586-98-1
Synonyms:2-(Hydroxymethyl)pyridine
2-Pyridinemethanol
pyridin-2-ylmethanol
piconol
2-HMP
a-Picolyl alcohol
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 222.6±0.0 °C at 760 mmHg
Melting Point 5 °C
Molecular Formula C6H7NO
Molecular Weight 109.126
Flash Point 81.7±20.4 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.551
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Neratinib(CAS:698387-09-6).



We are professional L-Menthyl glyoxylate hydrate manufacturer and a-Picolyl alcohol supplier in China, We offer quality pyridin-2-ylmethanol you can fully trust, also we have India factory and producer of 2,2-Dihydroxyacetic Acid (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl Ester,Pls send inquiry of L-Menthyl Glyoxylate Hydrate CAS:586-98-1 to info@nbinno.com if you have any interests, thank you!


Related News: At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.4-Bromo-2-Chlorobenzoic Acid Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.(2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.98198-48-2 China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.